Literature DB >> 8556492

Epitope-specific antibody response against glycoprotein E of pseudorabies virus.

L Jacobs1, T G Kimman.   

Abstract

In this study we investigated the epitope-specific antibody response against glycoprotein E (gE) of pseudorabies virus. Epitope-specific antibody responses were investigated by enzyme-linked immunoperoxidase monolayer assays. In a vaccinated crossbred pig population, most pigs responded to antigenic domain E and to a lesser degree to antigenic domains C and D. Only few pigs responded to antigenic domains F, A, and B. Using vaccinated pigs, we investigated the influence of two different pseudorabies virus strains and the genetic background of the host on the epitope-specific antibody response. More pigs infected with the virulent NIA-3 strain had a detectable antibody response against antigenic domains C, F and A than did pigs infected with the mildly virulent Sterksel strain (P < or = 0.05; Fisher's exact test). No differences in the epitope-specific antibody responses of two genetically different pig breeding lines were observed (P > or = 0.1; Fisher's exact test). In both breeding lines the incidence of the epitope-specific antibody response was comparable to that in the crossbred pig population. In addition, we studied the epitope-specific antibody responses were strikingly different and indicated that genetic background influenced the epitope-specific antibody response. Of the serum samples of mice with C57BL and a BALB background, 40 and 17% respectively, were positive in the one of the epitope-specific immunoassays. In contrast to pigs, mice responded predominantly to antigenic domain D and to a lesser degree to antigenic domains E and B. Only few mice had a detectable antibody response against antigenic domains C and A, and none had a detectable antibody response against antigenic domain F.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8556492      PMCID: PMC368322          DOI: 10.1128/cdli.1.5.500-505.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  17 in total

1.  Analysis of glycoprotein I (gI) negative and aberrant pseudorabies viral diagnostic isolates.

Authors:  J B Katz; J C Pederson
Journal:  Am J Vet Res       Date:  1992-12       Impact factor: 1.156

2.  Studies on immunisation of pigs with the Bartha strain of Aujeszky's disease virus.

Authors:  J B McFerran; C Dow
Journal:  Res Vet Sci       Date:  1975-07       Impact factor: 2.534

3.  Induction of antibodies to glycoprotein I in pigs exposed to different doses of a mildly virulent strain of Aujeszky's disease virus.

Authors:  J T van Oirschot
Journal:  Vet Rec       Date:  1988-06-18       Impact factor: 2.695

4.  Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay.

Authors:  J T van Oirschot; H J Rziha; P J Moonen; J M Pol; D van Zaane
Journal:  J Gen Virol       Date:  1986-06       Impact factor: 3.891

5.  Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies.

Authors:  T Ben-Porat; J M DeMarchi; B Lomniczi; A S Kaplan
Journal:  Virology       Date:  1986-10-30       Impact factor: 3.616

6.  Regeneration of herpesviruses from molecularly cloned subgenomic fragments.

Authors:  M van Zijl; W Quint; J Briaire; T de Rover; A Gielkens; A Berns
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

7.  A proposal for the nomenclature of antigenic sites in peptides and proteins.

Authors:  M Z Atassi; J A Smith
Journal:  Immunochemistry       Date:  1978-08

8.  Epitope analysis of glycoprotein I of pseudorabies virus.

Authors:  L Jacobs; R H Meloen; A L Gielkens; J T Van Oirschot
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

9.  Development of an ELISA to differentiate between animals either vaccinated with or infected by Aujeszky's disease virus.

Authors:  M Eloit; D Fargeaud; P Vannier; B Toma
Journal:  Vet Rec       Date:  1989-01-28       Impact factor: 2.695

10.  Identification of pseudorabies virus-exposed swine with a gI glycoprotein enzyme-linked immunosorbent assay.

Authors:  M W Mellencamp; N E Pfeiffer; B T Suiter; J R Harness; W H Beckenhauer
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

View more
  5 in total

1.  Development of a latex agglutination test using the major epitope domain of glycoprotein E of pseudorabies virus expressed in E. coli to differentiate between immune responses in pigs naturally infected or vaccinated with pseudorabies virus.

Authors:  Tang Yong; Chen Huan-chun; Xiao Shao-bo; Qin Ya-li; He Qi-gai; Ren Yu-qi
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

2.  An indirect double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) using baculovirus-expressed antigen for the detection of antibodies to glycoprotein E of pseudorabies virus and comparison of the method with blocking ELISAs.

Authors:  T G Kimman; O de Leeuw; G Kochan; B Szewczyk; E van Rooij; L Jacobs; J A Kramps; B Peeters
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

3.  Expression and purification of Suid Herpesvirus-1 glycoprotein E in the baculovirus system and its use to diagnose Aujeszky's disease in infected pigs.

Authors:  María Soledad Serena; Christoph Geisler; Germán Ernesto Metz; Santiago Gerardo Corva; Eduardo Carlos Mórtola; Alejandra Larsen; Donald L Jarvis; María Gabriela Echeverría
Journal:  Protein Expr Purif       Date:  2013-04-28       Impact factor: 1.650

4.  Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease.

Authors:  Peter Meerts; Gerald Misinzo; David Lefebvre; Jens Nielsen; Anette Bøtner; Charlotte S Kristensen; Hans J Nauwynck
Journal:  BMC Vet Res       Date:  2006-01-30       Impact factor: 2.741

5.  Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.

Authors:  Sonia Alejandra Romera; Mariana Puntel; Valeria Quattrocchi; Paula Del Médico Zajac; Patricia Zamorano; Javier Blanco Viera; Consuelo Carrillo; Shafiqul Chowdhury; Manuel V Borca; Ana M Sadir
Journal:  BMC Vet Res       Date:  2014-01-08       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.